23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...

On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

A DNA test uploaded into a public database in spring 2023 eventually led to the arrest of an 84-year-old man who is accused ...

Myriad Genetics and agency partner S50 Health educated OBGYNs and their patients in a campaign called “Getting Ahead of ...

Preventative speciality can diagnose rare and inherited health conditions but difficulty accessing the service is affecting ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Medicine is on the precipice of radical changes in diagnosis, personalised treatment, and the ability to prevent disease ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Genetic technology in medicine has evolved to the point where it is now being used to improve care and outcomes for ...

Me, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value ...

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.